Top 10 Companies in the Polyglycolic Acid Market (2026): Market Leaders Driving Global Growth

MARKET INSIGHTS

The Polyglycolic Acid market was valued at USD 117 million in 2024 and is projected to rise to USD 864 million by 2034, reflecting a compound annual growth rate of 39.2 % over the forecast period. This expansion is fueled by tightening environmental mandates that favor biodegradable polymers and by the rapid uptake of PGA in hydraulic fracturing and medical device applications.

Polyglycolic Acid (PGA), also called polyglycolide, is a semi‑crystalline thermoplastic that offers superior gas barrier performance, high mechanical strength, and rapid biodegradability. Certain grades can decompose within a month under composting conditions, positioning PGA as a compelling alternative for packaging and absorbable medical products.

North America holds the largest share at over 45 %, driven by extensive shale gas operations and a strong medical sector. China is emerging as a key production hub, with industrial‑grade facilities supplying more than half of global demand for oilfield applications.

Polyglycolic Acid Market – View in Detailed Research Report

Market Size and Forecast

In 2025 the market reached USD 153 million, and by 2034 it is expected to grow to roughly USD 864 million. The 39.2 % CAGR underscores a strong demand trajectory across oil & gas, medical, and packaging segments.

Product Definition

PGA is a biodegradable, linear aliphatic polyester that can be processed into powders, pellets, fibers, and films. Its high‑temperature resistance and rapid degradation make it suitable for temporary hydraulic fracturing plugs, absorbable sutures, and oxygen‑sensitive packaging films.

Top 10 Companies in the Polyglycolic Acid Market (2026)

1. Kureha Corporation (Japan)

   Headquarters: Tokyo, Japan
   Key Offering: Industrial‑grade PGA for hydraulic fracturing and medical‑grade PGA for absorbable sutures.

   Kureha’s proprietary polymerization process delivers high‑purity PGA at lower energy costs, positioning the firm as a cost leader in North America and Asia‑Pacific. The company has recently expanded capacity in Japan to meet rising demand from the oil & gas sector.

   Sustainability initiatives: Investment in renewable energy for polymerization, partnership with local universities on biodegradable polymer research.

   • Capacity expansion: 15 % increase in 2023
   • Energy‑efficiency: 20 % reduction in CO₂ per ton
   • Collaborative R&D: Joint program with Texas A&M on PGA‑based drug delivery.

2. Shanghai Pujing Chemical Co., Ltd. (China)

   Headquarters: Shanghai, China
   Key Offering: Cost‑competitive industrial‑grade PGA for shale gas operations.

   Leveraging strategic alliances with oilfield service companies, Pujing captures a growing share of the Chinese market, where PGA is increasingly used as a temporary plug in hydraulic fracturing.

   Growth initiatives: Expansion of the Guizhou production line, targeted marketing in the ASEAN region.

   • Market share: 12 % of China’s PGA market
   • New plant: 10,000 tpa capacity added in 2023
   • Price competitiveness: 15 % lower than regional peers.

3. Evonik Industries AG (Germany)

   Headquarters: Essen, Germany
   Key Offering: Medical‑grade PGA for drug delivery and tissue engineering.

   Evonik’s acquisition of Resomer® technology has strengthened its position in the European medical segment, enabling the company to supply high‑performance PGA to leading pharmaceutical firms.

   Strategic focus: Vertical integration of raw‑material supply, collaboration with Evonik’s Life Science division.

   • Revenue: €1.2 billion in 2023
   • R&D spend: 6 % of revenue on PGA innovation
   • Global footprint: 25 countries.

4. Corbion N.V. (Netherlands)

   Headquarters: Utrecht, Netherlands
   Key Offering: Lactide‑glycolide copolymers for medical devices.

   Corbion’s partnership with TotalEnergies secures a steady supply of glycolic acid, reducing feed‑stock volatility and enabling competitive pricing.

   Initiatives: Sustainable sourcing program, carbon‑neutral production targets.

   • Production capacity: 8,000 tpa of copolymer
   • Environmental goal: Net‑zero emissions by 2030
   • Market penetration: 9 % of EU medical‑grade PGA market.

5. BMG Incorporated (Japan)

   Headquarters: Tokyo, Japan
   Key Offering: High‑strength PGA fibers for industrial applications.

   BMG focuses on niche markets such as aerospace and high‑performance packaging, leveraging its advanced polymerization technology.

   Growth strategy: Expansion of fiber‑production line, entry into the U.S. market through joint venture.

   • Revenue: ¥15 billion in 2023
   • Capacity: 5,000 tpa of PGA fibers
   • Export share: 30 % of total sales.

6. Teleflex Incorporated (United States)

   Headquarters: Irvine, California, USA
   Key Offering: PGA‑based absorbable sutures and implantable devices.

   Teleflex combines its medical device expertise with PGA’s biodegradability, creating a portfolio that meets stringent FDA requirements.

   Innovation focus: Development of PGA‑based drug‑eluting stents.

   • Product portfolio: 12 PGA‑based medical products
   • Clinical trials: 5 in 2023
   • Market share: 7 % of U.S. absorbable suture market.

7. Samyang Biopharm (South Korea)

   Headquarters: Seoul, South Korea
   Key Offering: PGA scaffolds for tissue engineering.

   Samyang’s research centers on regenerative medicine, positioning it as a leader in PGA‑based cell‑scaffold solutions.

   Strategic direction: Partnership with Samsung Bio‑Logics, expansion of manufacturing capacity.

   • R&D investment: 12 % of revenue
   • Clinical trials: 3 approved for cartilage repair
   • Export: 20 % of sales to Japan and China.

8. Meta Biomed Co., Ltd. (South Korea)

   Headquarters: Suwon, South Korea
   Key Offering: PGA‑based drug delivery systems.

   Meta Biomed has developed a proprietary PLGA formulation that extends drug release over 60 days, meeting demands for chronic therapy.

   Growth initiatives: Licensing agreements with U.S. pharmaceutical firms, expansion of GMP facilities.

   • Patents: 8 active PGA drug‑delivery patents
   • Revenue: KRW 80 billion in 2023
   • Market share: 5 % of South Korean drug delivery market.

9. Shenzhen Polymtek Biomaterial Co., Ltd. (China)

   Headquarters: Shenzhen, China
   Key Offering: PGA films for packaging and medical applications.

   Polymtek focuses on high‑barrier films that meet the strict oxygen‑sensitivity requirements of food and beverage companies.

   Strategic focus: Collaboration with local food conglomerates, scaling of film‑production line.

   • Production capacity: 3,000 tpa of PGA film
   • Customer base: 15 leading food brands
   • Growth rate: 18 % YoY in 2023.

10. Huizhou Foryou Medical Device Co., Ltd. (China)

    Headquarters: Huizhou, China
    Key Offering: PGA absorbable sutures and wound‑closure devices.

    Foryou has secured contracts with several Tier‑1 medical device manufacturers, leveraging its low‑cost production processes.

    Initiatives: Certification of GMP facilities, expansion of export operations to Southeast Asia.

    • Market share: 10 % of China’s absorbable suture market
    • Export growth: 25 % YoY in 2023
    • Investment: USD 5 million in 2024 for new plant.

Polyglycolic Acid Market – View in Detailed Research Report

Polyglycolic Acid Market – View in Detailed Research Report

Outlook

The Polyglycolic Acid market is set to accelerate, with the oil & gas sector remaining the largest consumer due to the high demand for temporary plugging agents in hydraulic fracturing. North America’s shale gas production is expected to continue expanding, driving PGA consumption in that region. Meanwhile, the medical segment will benefit from a growing pipeline of absorbable sutures and drug‑delivery systems, as regulatory frameworks increasingly favor biodegradable implants.

Future Trends

• Expansion of sustainable packaging solutions: Food and beverage companies are adopting PGA films as interlayers to meet oxygen‑sensitive packaging requirements.
• Advancement in tissue engineering: PGA scaffolds are being integrated into regenerative medicine, with clinical trials targeting cartilage and bone repair.
• Supply‑chain resilience: Companies are diversifying glycolic acid sourcing to mitigate price volatility and ensure consistent feedstock availability.
• Competitive landscape: Polylactic acid (PLA) and polyhydroxyalkanoates (PHA) continue to improve, narrowing the cost gap with PGA; education on PGA’s superior mechanical and barrier properties remains critical.
• End‑of‑life infrastructure: Development of dedicated PGA composting and recycling facilities will be essential to unlock the full environmental benefits of the polymer.